BACKGROUND: Depression is common after a cardiac event, yet there remain few approaches to management that are both effective and scalable. PURPOSE: We aimed to evaluate the 6-month efficacy and feasibility of a tele-health program (MoodCare) that integrates depression management into a cardiovascular disease risk reduction program for acute coronary syndrome patients with low mood. METHODS: A two-arm, parallel, randomized design was used comprising 121 patients admitted to one of six hospitals for acute coronary syndrome. RESULTS: Significant treatment effects were observed for Patient Health Questionnaire 9 (PHQ9) depression (mean difference [change] = -1.8; p = 0.025; effect size: d = 0.36) for the overall sample, when compared with usual medical care. Results were more pronounced effects for those with a history of depression (mean difference [change] = -2.7; p = 0.043; effect size: d = 0.65). CONCLUSIONS:MoodCare was effective for improving depression in acute coronary syndrome patients, producing effect sizes exceeding those of some face-to-face psychotherapeutic interventions and pharmacotherapy. ( TRIAL REGISTRATION NUMBER: ACTRN1260900038623.).
RCT Entities:
BACKGROUND:Depression is common after a cardiac event, yet there remain few approaches to management that are both effective and scalable. PURPOSE: We aimed to evaluate the 6-month efficacy and feasibility of a tele-health program (MoodCare) that integrates depression management into a cardiovascular disease risk reduction program for acute coronary syndromepatients with low mood. METHODS: A two-arm, parallel, randomized design was used comprising 121 patients admitted to one of six hospitals for acute coronary syndrome. RESULTS: Significant treatment effects were observed for Patient Health Questionnaire 9 (PHQ9) depression (mean difference [change] = -1.8; p = 0.025; effect size: d = 0.36) for the overall sample, when compared with usual medical care. Results were more pronounced effects for those with a history of depression (mean difference [change] = -2.7; p = 0.043; effect size: d = 0.65). CONCLUSIONS: MoodCare was effective for improving depression in acute coronary syndromepatients, producing effect sizes exceeding those of some face-to-face psychotherapeutic interventions and pharmacotherapy. ( TRIAL REGISTRATION NUMBER: ACTRN1260900038623.).
Authors: Suzanne H Richards; Lindsey Anderson; Caroline E Jenkinson; Ben Whalley; Karen Rees; Philippa Davies; Paul Bennett; Zulian Liu; Robert West; David R Thompson; Rod S Taylor Journal: Cochrane Database Syst Rev Date: 2017-04-28
Authors: Juliana Zambrano; Christopher M Celano; James L Januzzi; Christina N Massey; Wei-Jean Chung; Rachel A Millstein; Jeff C Huffman Journal: J Am Heart Assoc Date: 2020-11-07 Impact factor: 5.501
Authors: Lauren M Young; Steve Moylan; Tayla John; Megan Turner; Rachelle Opie; Meghan Hockey; Dean Saunders; Courtney Bruscella; Felice Jacka; Megan Teychenne; Simon Rosenbaum; Khyati Banker; Sophie Mahoney; Monica Tembo; Jerry Lai; Niamh Mundell; Grace McKeon; Murat Yucel; Jane Speight; Pilvikki Absetz; Vincent Versace; Mary Lou Chatterton; Michael Berk; Sam Manger; Mohammadreza Mohebbi; Mark Morgan; Anna Chapman; Craig Bennett; Melissa O'Shea; Tetyana Rocks; Sarah Leach; Adrienne O'Neil Journal: BMC Psychiatry Date: 2022-03-27 Impact factor: 3.630